Showing 2391-2400 of 3223 results for "".
- Santen Launches Verkazia for Children and Adolescents with Severe Allergic Eye Conditionhttps://modernod.com/news/santen-launches-verkazia-for-children-and-adolescents-with-severe-allergic-eye-condition/2479744/Santen UK announced the launch of Verkazia eye drops emulsion containing 0.1% (1mg/ml) ciclosporin for the treatment of the rare disease severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents. Verkazia, which has been granted orphan drug status, provides a much-n
- Falls in Elders May Be Driving Up Secondary Diagnoses of Eye Traumahttps://modernod.com/news/falls-in-elders-may-be-driving-up-secondary-diagnoses-of-eye-trauma/2479788/Hospital admissions due to eye trauma have declined since 2001, but more and more patients are being admitted with a secondary diagnosis of eye trauma, largely due to an increase in falls among older people, new findings suggest, according to a Reuters
- Silgan Dispensing Introduces Iridya Eye Dropper to Ensure Accurate Doses Down to the Drophttps://modernod.com/news/silgan-dispensing-introduces-iridya-eye-dropper-to-ensure-accurate-doses-down-to-the-drop/2479804/Silgan Dispensing has launched Iridya, a next-generation, multi-dose preservative-free eye dropper. The Iridya eye dropper ensures consumers an accurate dose and an easy-to-use design, while also providing safe delivery of ophthalmic medication. Its elongated tip provides greater accuracy when di
- CMS Proposes to Eliminate Medicare Certification Requirements for Comprehensive H&Ps and Transfer Agreements with Hospitalshttps://modernod.com/news/cms-proposes-to-eliminate-medicare-certification-requirements-for-comprehensive-hps-and-transfer-agreements-with-hospitals/2479844/The Outpatient Ophthalmic Surgery Society (OOSS) issued the following statement in response to recent changes in the Centers for Medicare & Medicaid Services (CMS) Medicare payment policy concerning ambulatory surgery centers (ASCs). “Last week, CMS proposed reducing, modifying,
- Oculis Elects Anthony Rosenberg and David A. Weber to Its Board of Directorshttps://modernod.com/news/oculis-elects-anthony-rosenberg-and-david-a-weber-to-its-board-of-directors/2479867/Oculis announced the appointments of Anthony Rosenberg as Non-Executive Chairman and David A. Weber, PhD, as Non-Executive Director. Together, they bring more than 60 years’ experience from the global pharmaceutical and eye care industries to the compa
- Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Boardhttps://modernod.com/news/alzheimers-therapeutics-research-leader-dr-roy-twyman-joins-neurovision-imaging-board/2480013/Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years’ experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Board of Directors on July 20. NeuroVision is developing and studying an experimental, breakthrough, low-cost, noninvasive,
- Abom Announces Sales Alliance with Essilor Prescription Safety Eyewear for RX with Advanced Anti-Fog Technologyhttps://modernod.com/news/abom-announces-sales-alliance-with-essilor-prescription-safety-eyewear-for-rx-with-advanced-anti-fog-technology/2480049/Abom, a manufacturer of anti-fogging heated goggles with integrated rechargeable batteries, announced the newest addition to its line of products, the Abom HEET RX goggle anti-fog solution. The HEET RX features the second generation of Abom’s award-winning heated goggle technology, improving upon
- Novartis Confirms 2018 Targets as Alcon Recovery Gains Steamhttps://modernod.com/news/novartis-confirms-2018-targets-as-alcon-recovery-gains-steam/2480224/Swiss drugmaker Novartis’ first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit, according to a
- Researchers in Japan Link Drinking Habits to Faster Progression of Presbyopiahttps://modernod.com/news/researchers-in-japan-link-drinking-habits-to-faster-progression-of-presbyopia/2487228/A new study suggests that alcohol consumption may speed up the progression of presbyopia, particularly in men. Researchers say the findings add to growing evidence that l
- Viridian Therapeutics Reports Positive Phase 3 Results for Thyroid Eye Disease Drughttps://modernod.com/news/viridian-therapeutics-reports-positive-phase-3-results-for-thyroid-eye-disease-drug/2486956/Key Takeaways Elegrobart significantly improved key symptoms of chronic thyroid eye disease in a phase 3 trial, with responder rates exceeding placebo